Abstract
The application describes the synthesis of 1H-pyrazolo[4,3-H]quinazoline compounds for treating cell proliferation dysfunction and is a broad-spectrum and strongly-active inhibitor for a cell cyclin-dependent kinase (CDK).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have